Preeclampsia Research
Last Updated on January 23, 2020
is a leading cause of
maternal mortality
and prematurity
Preeclampsia, once known as toxemia, includes eclampsia and HELLP syndrome
U.S. ranks
worldwide and is the only industrialized nation with rising maternal mortality
Pregnancy risk
pregnancies (5% to 8%) are affected by preeclampsia
African Americans
African American women are 3x more likely to die from preeclampsia
Prematurity
of medically necessary preterm deliveries are due to preeclampsia
Postpartum
of maternal deaths associated with preeclampsia occur after delivery
Mental health
Women who experience preeclampsia are 4x more likely to develop PTSD
Near-misses
For every pregnancy-related death, there are at least 50x more "near-misses"
Deaths annually
maternal deaths and 500,000 infant deaths are attributed to preeclampsia worldwide
Preventable
of maternal deaths due to preeclampsia are preventable
Patient registry
Members strong, the Preeclampsia Registry unites the patient experience with clinical data, creating a significant resource for researchers to find ways to prevent, diagnose, treat, and cure preeclampsia.
Now we need to double it!
Research grants
Awarded annually through research grants including the Peter Joseph Pappas Research Grant and Vision Grant programs
Thanks to our donors, over $1MILLION in research has been funded!
Apply now
Who qualifies to enroll in the Preeclampsia Registry?
- If you have experienced preeclampsia
- If your family has experienced preeclampsia
- If you have not had preeclampsia
Every one can play a role in preeclampsia research!
Enroll Today login
Related Articles
Answers to our most frequently asked questions about the registry
Everyone can play a role in preeclampsia research. Enroll Today login
The Preeclampsia Registry is a valuable resource that you can turn to when posing new questions, testing new hypotheses, and building study cohorts. As a “living database” that i...
According to the World Health Organization, preeclampsia is one of the least funded areas of research, especially when considered against Disability Adjusted Life Years (DALYs). The Preeclampsia Found...
The Letter of Intent period is CLOSED for the 2020 Peter Joseph Pappas Research Grants funding program. Decisions will be rendered in December 2020 and the next funding round will be announced next ye...
1611603463.png)
High Blood Pressure During Pregnancy May Be a Warning Sign of Life-threatening Condition World’s Leading Clinicians and Researchers to Discuss Best Practices for Predicting, Preventing, and M...
Melbourne, FL – December 30, 2020 – The Preeclampsia Foundation announces the recipients of its 2021 Peter Joseph Pappas Research Grants, a funding program designed to accelerate p...
Title: Vitamin D in the womb may be protective for babies born from pregnancies complicated by preeclampsia Article Title: Associations of Cord Blood Vitamin D and Preeclampsia With Offspring B...
August 6, 2020 – Melbourne, FL – The Preeclampsia Foundation is seeking Letters of Intent for the Peter Joseph Pappas Research Grants funding program, designed to accelerate preeclampsia r...
TREATMENT Results of a trial to test a new medication for preterm preeclampsia: the PRESERVE-1 Trial AJOG Preterm preeclampsia is a rare form of preeclampsia that occurs at 23-30 weeks of...